Correlation Between Pfizer and 87264AAT2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and T Mobile USA 5375, you can compare the effects of market volatilities on Pfizer and 87264AAT2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 87264AAT2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 87264AAT2.
Diversification Opportunities for Pfizer and 87264AAT2
Very weak diversification
The 3 months correlation between Pfizer and 87264AAT2 is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and T Mobile USA 5375 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T Mobile USA and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 87264AAT2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T Mobile USA has no effect on the direction of Pfizer i.e., Pfizer and 87264AAT2 go up and down completely randomly.
Pair Corralation between Pfizer and 87264AAT2
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 87264AAT2. In addition to that, Pfizer is 3.32 times more volatile than T Mobile USA 5375. It trades about -0.08 of its total potential returns per unit of risk. T Mobile USA 5375 is currently generating about 0.0 per unit of volatility. If you would invest 10,068 in T Mobile USA 5375 on September 5, 2024 and sell it today you would lose (98.00) from holding T Mobile USA 5375 or give up 0.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.39% |
| Values | Daily Returns |
Pfizer Inc vs. T Mobile USA 5375
Performance |
| Timeline |
| Pfizer Inc |
| T Mobile USA |
Pfizer and 87264AAT2 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 87264AAT2
The main advantage of trading using opposite Pfizer and 87264AAT2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 87264AAT2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 87264AAT2 will offset losses from the drop in 87264AAT2's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| 87264AAT2 vs. The Travelers Companies | 87264AAT2 vs. GE Aerospace | 87264AAT2 vs. Walmart | 87264AAT2 vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |